Materiais bioativos para pulpotomias em dentição decídua: revisão da literatura
DOI:
https://doi.org/10.20453/reh.v35i2.5751Palavras-chave:
anticoagulantes, cirurgia bucal, coagulação sanguínea, odontologiaResumo
Durante décadas, os antagonistas da vitamina K, como a varfarina, foram a terapia anticoagulante padrão ouro, apesar das dificuldades associadas ao seu manejo clínico. Em contraste, os anticoagulantes orais de ação direta (DOAC) oferecem menos complicações e vantagens terapêuticas. Eles são divididos em inibidores de trombina (dabigatran) e inibidores do fator Xa (rivaroxaban, apixaban, edoxaban). Aproximadamente 10% das pessoas anticoaguladas precisarão de cirurgia, inclusive cirurgia oral. Nesse contexto, o objetivo desta revisão foi atualizar o manejo cirúrgico oral em pacientes anticoagulados e familiarizar os dentistas com os protocolos em usuários de varfarina e DOAC. A interrupção da terapia anticoagulante envolve riscos significativos e até mesmo fatais, superando em muitos casos os benefícios da redução do sangramento em cirurgia bucal. Conclui-se que a descontinuação de anticoagulantes só deve ser considerada em procedimentos com alto risco de sangramento, com avaliação prévia do risco hemorrágico do procedimento e aplicação de medidas hemostáticas, se necessário.
Downloads
Referências
Costa e Silva LL, Cosme-Silva L, Sakai VT, Lopes CS, Silveira AP, Moretti Neto RT, et al. Comparison between calcium hydroxide mixtures and mineral trioxide aggregate in primary teeth pulpotomy: a randomized controlled trial. J Appl Oral Sci [Internet]. 2019; 27: e20180030. Disponible en: https://doi.org/10.1590/1678-7757-2018-0030
Reynoso NP, Leyda AM, Ribelles M. Pulpotomía en dentición primaria: un análisis bibliométrico de 57 años. Rev Odontopediatr Latinoam [Internet]. 2022; 12(1): e-320333. Disponible en: https://doi.org/10.47990/alop.v12i1.333
Buzo P, Manríquez J, González B, Prieto M, Gutiérrez I, Palacios F. Comparación del uso de formocresol vs. biodentine/MTA en pulpotomías; revisión sistemática. Rev Op Dent Biomater [Internet]. 2021; 10(2): 15-21. Disponible en: https://www.rodyb.com/wp-content/uploads/2021/05/3-formocresol-vs-biodentine-.pdf
Santaella J, Palencia L, Weffer R. Materiales más utilizados en tratamientos endodónticos de dientes primaries. Revisión bibliográfica. RODYB [Internet]. 2021; 10(2): 31-39. Disponible en: https://www.rodyb.com/wp-content/uploads/2021/05/5-materiales-mas-usados.pdf
Cedillo J, Domínguez A, Espinosa R. Materiales bioactivos en odontología restauradora. RODYB [Internet]. 2021; 10(3): 19-29. Disponible en: https://www.rodyb.com/wp-content/uploads/2021/08/3-materiales-bioactivoa.pdf
Abdelwahab DH, Kabil NS, Badran AS, Darwish D, Abd El Geleel OM. One-year radiographic and clinical performance of bioactive materials in primary molar pulpotomy: a randomized controlled trial. J Dent [Internet]. 2024; 143: 104864. Disponible en: https://doi.org/10.1016/j.jdent.2024.104864
Mushtaq A, Nangia T, Goswami M. Comparative evaluation of the treatment outcomes of pulpotomy in primary molars using mineral trioxide aggregate and 3mixtatin: a randomized clinical trial. Int J Clin Pediatr Dent [Internet]. 2023; 16(6): 782-787. Disponible en: https://doi.org/10.5005/jp-journals-10005-2720
Alqahtani AS, Alsuhaibani NN, Sulimany AM, Bawazir OA. NeoPUTTY® versus NeoMTA 2® as a pulpotomy medicament for primary molars: a randomized clinical trial. Pediatr Dent [Internet]. 2023; 45(3): 240-244. Disponible en: https://www.ingentaconnect.com/content/aapd/pd/2023/00000045/00000003/art00008;jsessionid=5r44pmmf58eif.x-ic-live-02
Alnassar I, Altinawi M, Rekab MS, Alzoubi H, Abdo A. Evaluation of the efficacy of mineral trioxide aggregate and bioceramic putty in primary molar pulpotomy with symptoms of irreversible pulpitis (a randomized‐controlled trial). Clin Exp Dent Res [Internet]. 2023; 9(2): 276-282. Disponible en: https://doi.org/10.1002/cre2.700
Hidalgo LR, Almeida-Junior LA, Lucisano Politi MP, Nelson-Filho P, Segato RA, Paula-Silva FW, et al. Randomized clinical study of the use of MTA and BiodentineTM for pulpotomy in primary teeth. Pesqui Bras Odontopediatria Clín Integr [Internet]. 2023; 23: e220024. Disponible en: https://doi.org/10.1590/pboci.2023.081
Hassanpour S, Aminabadi NA, Rahbar M, Erfanparast L. Comparison between the radiographic and clinical rates of success for TheraCal and MTA in primary tooth pulpotomy within a 12-month follow-up: a split-mouth clinical trial. BioMed Res Int [Internet]. 2023; 2023(1): 8735145. Disponible en: https://doi.org/10.1155/2023/8735145
Kiranmayi T, Vemagiri CT, Rayala C, Chandrappa V, Bathula H, Challagulla A. In vivo comparison of bioceramic putty and mineral trioxide aggregate as pulpotomy medicament in primary molars. A 12-month follow-up randomized clinical trial. Dent Res J [Internet]. 2022; 19(1): 84. Disponible en: https://doi.org/10.4103/1735-3327.359322
Eshghi A, Hajiahmadi M, Nikbakht MH, Esmaeili M. Comparison of clinical and radiographic success between MTA and biodentine in pulpotomy of primary mandibular second molars with irreversible pulpitis: a randomized double-blind clinical trial. Int J Dent [Internet]. 2022; 2022(1): 6963944. Disponible en: https://doi.org/10.1155/2022/6963944
Vilella-Pastor S, Sáez S, Veloso A, Guinot-Jimeno F, Mercadé M. Long-term evaluation of primary teeth molar pulpotomies with Biodentine and MTA: a CONSORT randomized clinical trial. Eur Arch Paediatr Dent [Internet]. 2021; 22(4): 685-692. Disponible en: https://doi.org/10.1007/s40368-021-00616-3
Lima SP, Santos GL, Ferelle A, Ramos SP, Pessan JP, Dezan-Garbelini CC. Clinical and radiographic evaluation of a new stain-free tricalcium silicate cement in pulpotomies. Braz Oral Res [Internet]. 2020; 34: e102. Disponible en: https://doi.org/10.1590/1807-3107bor-2020.vol34.0102
Öznurhan F, Kayabasi M, kesküs B. Evaluation of long-term results of two different calcium silicate based materials in primary molar teeth vital pulpotomies: an in vivo study. Cumhuriyet Dent J [Internet]. 2020; 23(1): 45-51. Disponible en: http://dx.doi.org/10.7126/cumudj.648723
Meslmani W, Kouchaji C, Rekab S, Abo Fakher MA, Al Nerabieah Z. The efficacy of Portland cement as a pulpotomy agent in deciduous teeth. Pediatr Dent J [Internet]. 2020; 30(2): 99-105. Disponible en: https://doi.org/10.1016/j.pdj.2020.02.001
Esen M, Guven Y, Seyhan MF, Ersev H, Tuna-Ince EB. Evaluation of the genotoxicity, cytotoxicity, and bioactivity of calcium silicate-based cements. BMC Oral Health [Internet]. 2024; 24: 119. Disponible en: https://doi.org/10.1186/s12903-024-03891-w
Kim B, Lee YH, Kim IH, Lee KE, Kang CM, Lee HS, et al. Biocompatibility and mineralization potential of new calcium silicate cements. J Dent Sci [Internet]. 2023; 18(3): 1189-1198. Disponible en: https://doi.org/10.1016/j.jds.2022.10.004
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Copyright (c) 2025 Nayda Mirelly Guevara Purizaca, María Elizabeth Cruz Flores, Rosa Josefina Roncal Espinoza, Alfredo Carlos Manuel Rendon Alvarado
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
Os autores mantêm os direitos autorais e cedem à revista o direito de primeira publicação, sendo o trabalho registrado com a Licença Creative Commons, que permite que terceiros utilizem o que é publicado desde que mencionem a autoria do trabalho, e ao primeiro publicação nesta revista.
